Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Top Cited Papers
Open Access
- 8 December 2011
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 118 (24), 6239-6246
- https://doi.org/10.1182/blood-2011-09-377275
Abstract
In a previous study, we identified somatic mutations of SF3B1, a gene encoding a core component of RNA splicing machinery, in patients with myelodyspKeywords
This publication has 43 references indexed in Scilit:
- Molecular Biology of Myelodysplastic SyndromesSeminars in Oncology, 2011
- SomaticSF3B1Mutation in Myelodysplasia with Ring SideroblastsNew England Journal of Medicine, 2011
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesNew England Journal of Medicine, 2011
- A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q– syndromeNature Medicine, 2009
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotypeNature Medicine, 2009
- Mutation inTET2in Myeloid CancersNew England Journal of Medicine, 2009
- Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal‐ and translation‐related genesBritish Journal of Haematology, 2008
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screenNature, 2008
- New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patientsBlood, 2007
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974